Basic Information
StratifAI Develops Multimodal AI Models to Provide Prognostic Insights from Routinely Available Histological Images and Clinical Data, Guiding Oncology Treatment Decisions. The company leverages expertise in biomarker discovery, clinical trial data analysis, large language models and information retrieval, as well as multimodal data integration, to advance cancer therapies and enable pharmaceutical companies to develop personalized treatments for cancer patients.
StratifAI
Dresden,FreeStateofSaxony,Germany
15~50 people
January 01, 2023
--

